The treatment of cervical dystonia with botulinum toxins (original) (raw)
R Benecke WH Jost P Kanovsky E Ruzicka G Comes S Grafe (2005)ArticleTitleA new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia_Neurology_ 64 1949–1951Occurrence Handle15955951Occurrence Handle10.1212/01.WNL.0000163767.99354.C3Occurrence Handle1:CAS:528:DC%2BD2MXksVaisLc%3D ArticlePubMedCAS Google Scholar
B Berman L Seeberger R Kumar (2004)ArticleTitleLong-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia_Mov Disord_ 20 233–237Occurrence Handle10.1002/mds.20290 Article Google Scholar
JW Brans R Lindeboom JW Snoek MJ Zwarts TW van Weerden ER Brunt JJ van Hilten W van der Kamp MH Prins JD Speelman (1996)ArticleTitleBotulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial_Neurology_ 46 1066–1072Occurrence Handle8780093Occurrence Handle1:STN:280:DyaK28zntlyjsA%3D%3D PubMedCAS Google Scholar
A Brashear MF Lew DD Dykstra CL Comella SA Factor RL Rodnitzky R Trosch C Singer MF Brin JJ Murray JD Wallace A Willmer-Hulme M Koller (1999)ArticleTitleSafety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia_Neurology_ 53 1439–1446Occurrence Handle10534248Occurrence Handle1:CAS:528:DyaK1MXntlWhu7g%3D PubMedCAS Google Scholar
A Brashear K Bergan J Wojcieszek ER Siemers W Ambrosius (2000)ArticleTitlePatient’s perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A_Mov Disord_ 15 150–153Occurrence Handle10634256Occurrence Handle10.1002/1531-8257(200001)15:1<150::AID-MDS1024>3.0.CO;2-XOccurrence Handle1:STN:280:DC%2BD3c%2FpslOhsA%3D%3D ArticlePubMedCAS Google Scholar
MF Brin MF Lew CH Adler CL Comella SA Factor J Jankovic C O’Brien JJ Murray JD Wallace A Willmer-Hulme M Koller (1999)ArticleTitleSafety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia_Neurology_ 53 1431–1438Occurrence Handle10534247Occurrence Handle1:CAS:528:DyaK1MXntlWhu7s%3D PubMedCAS Google Scholar
L Camfield Y Ben-Shlomo TT Warner (2002)ArticleTitleImpact of cervical dystonia on quality of life_Mov Disord_ 17 838–841Occurrence Handle12210891Occurrence Handle10.1002/mds.10127 ArticlePubMed Google Scholar
J Chan MF Brin S Fahn (1991)ArticleTitleIdiopathic cervical dystonia: clinical characteristics_Mov Disord_ 6 119–126Occurrence Handle2057004Occurrence Handle10.1002/mds.870060206Occurrence Handle1:STN:280:DyaK3M3nvVyqsw%3D%3D ArticlePubMedCAS Google Scholar
CL Comella J Jankovic KM Shannon J Tsui M Swenson S Leurgans W Fan (2005)ArticleTitleComparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia_Neurology_ 65 1423–1429Occurrence Handle16275831Occurrence Handle10.1212/01.wnl.0000183055.81056.5cOccurrence Handle1:STN:280:DC%2BD2Mrps12ltg%3D%3D ArticlePubMedCAS Google Scholar
SR Filipovic M Jahanshahi R Viswanathan P Heywood D Rogers KP Bhatia (2004)ArticleTitleClinical features of the geste antagoniste in cervical dystonia_Adv Neurol_ 94 191–201Occurrence Handle14509673 PubMed Google Scholar
DJ Gelb DH Lowenstein MJ Aminoff (1989)ArticleTitleControlled trial of botulinum toxin injections in the treatment of spasmodic torticollis_Neurology_ 39 80–84Occurrence Handle2642616Occurrence Handle1:STN:280:DyaL1M%2Fot1ymuw%3D%3D PubMedCAS Google Scholar
N Giladi J Meer H Kidan S Honigman (2000)ArticleTitleLong-term remission of idiopathic cervical dystonia after treatment with botulinum toxin_Eur Neurol_ 44 144–146Occurrence Handle11053961Occurrence Handle10.1159/000008223Occurrence Handle1:CAS:528:DC%2BD3cXotVCquro%3D ArticlePubMedCAS Google Scholar
P Greene U Kang S Fahn M Brin C Moskowitz E Flaster (1990)ArticleTitleDouble-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis_Neurology_ 40 1213–1218Occurrence Handle2199847Occurrence Handle1:STN:280:DyaK3czktVCrug%3D%3D PubMedCAS Google Scholar
JM Hagenah A Vieregge P Vieregge (2001)ArticleTitleRadiculopathy and myelopathy in patients with primary cervical dystonia_Eur Neurol_ 45 236–240Occurrence Handle11385261Occurrence Handle10.1159/000052135Occurrence Handle1:STN:280:DC%2BD3MzhtFyjtg%3D%3D ArticlePubMedCAS Google Scholar
J Jankovic S Leder D Warner K Schwartz (1991)ArticleTitleCervical dystonia: clinical findings and associated movement disorders_Neurology_ 41 1088–1091Occurrence Handle2067638Occurrence Handle1:STN:280:DyaK3M3ps1WhsA%3D%3D PubMedCAS Google Scholar
J Jankovic KD Vuong J Ahsan (2003)ArticleTitleComparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia_Neurology_ 60 1186–1188Occurrence Handle12682332Occurrence Handle1:STN:280:DC%2BD3s7msFSgtw%3D%3D PubMedCAS Google Scholar
KR Kessler M Skutta R Benecke (1999)ArticleTitleLong-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group_J Neurol_ 246 265–274Occurrence Handle10367694Occurrence Handle10.1007/s004150050345Occurrence Handle1:STN:280:DyaK1M3psVWitg%3D%3D ArticlePubMedCAS Google Scholar
MF Lew BT Adornato DD Duane DD Dykstra SA Factor JM Massey MF Brin J Jankovic RL Rodnitzky C Singer MR Swenson D Tarsy JJ Murray M Koller JD Wallace (1997)ArticleTitleBotulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia_Neurology_ 49 701–707Occurrence Handle9305326Occurrence Handle1:CAS:528:DyaK2sXmtlOmsbk%3D PubMedCAS Google Scholar
IT Lorentz SS Subramaniam C Yiannikas (1991)ArticleTitleTreatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients_Mov Disord_ 6 145–150Occurrence Handle2057005Occurrence Handle10.1002/mds.870060210Occurrence Handle1:STN:280:DyaK3M3nvVyqtw%3D%3D ArticlePubMedCAS Google Scholar
A Marchetti R Magar L Findley JP Larsen Z Pirtosek E Ruzicka R Jech J Slawek F Ahmed (2005)ArticleTitleRetrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study_Mov Disord_ 20 937–944Occurrence Handle15810022Occurrence Handle10.1002/mds.20468 ArticlePubMed Google Scholar
T Odergren H Hjaltason S Kaakkola G Solders J Hanko C Fehling RJ Marttila H Lundh S Gedin I Westergren A Richardson C Dott H Cohen (1998)ArticleTitleA double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia_J Neurol Neurosurg Psychiatry_ 64 6–12Occurrence Handle9436720Occurrence Handle1:STN:280:DyaK1c%2Fpslahsg%3D%3D PubMedCAS Google Scholar
W Poewe L Schelosky B Kleedorfer F Heinen M Wagner G Deuschl (1992)ArticleTitleTreatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients_J Neurol_ 239 21–25Occurrence Handle1541964Occurrence Handle10.1007/BF00839206Occurrence Handle1:STN:280:DyaK387ns12lsA%3D%3D ArticlePubMedCAS Google Scholar
W Poewe G Deuschl A Nebe E Feifel J Wissel R Benecke KR Kessler AO Ceballos-Baumann A Ohly W Oertel G Kunig (1998)ArticleTitleWhat is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group_J Neurol Neurosurg Psychiatry_ 64 13–17Occurrence Handle9436721Occurrence Handle1:STN:280:DyaK1c%2Fpslahsw%3D%3DOccurrence Handle10.1136/jnnp.64.1.13 ArticlePubMedCAS Google Scholar
D Ranoux C Gury J Fondarai JL Mas M Zuber (2002)ArticleTitleRespective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia_J Neurol Neurosurg Psychiatry_ 72 459–462Occurrence Handle11909903Occurrence Handle1:STN:280:DC%2BD387nslejsQ%3D%3D PubMedCAS Google Scholar
C Sampaio J Costa JJ Ferreira (2004)ArticleTitleClinical comparability of marketed formulations of botulinum toxin_Mov Disord_ 19 IssueIDSuppl 8 S129–S136Occurrence Handle15027065Occurrence Handle10.1002/mds.20066 ArticlePubMed Google Scholar
CM Shaari I Sanders (1993)ArticleTitleQuantifying how location and dose of botulinum toxin injections affect muscle paralysis_Muscle Nerve_ 16 964–969Occurrence Handle8355728Occurrence Handle10.1002/mus.880160913Occurrence Handle1:STN:280:DyaK3szmtFSmsg%3D%3D ArticlePubMedCAS Google Scholar
CM Shaari BL Wu HF Biller SK Chuang I Sanders (1998)ArticleTitleBotulinum toxin decreases salivation from canine submandibular glands_Otolaryngol Head Neck Surg_ 118 452–457Occurrence Handle9560094Occurrence Handle10.1016/S0194-5998(98)70200-1Occurrence Handle1:STN:280:DyaK1c3hvFShsw%3D%3D ArticlePubMedCAS Google Scholar
D Truong DD Duane J Jankovic C Singer LC Seeberger CL Comella MF Lew RL Rodnitzky FO Danisi JP Sutton PD Charles RA Hauser GL Sheean (2005)ArticleTitleEfficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study_Mov Disord_ 20 783–791Occurrence Handle15736159Occurrence Handle10.1002/mds.20403 ArticlePubMed Google Scholar
JK Tsui A Eisen E Mak J Carruthers A Scott DB Calne (1985)ArticleTitleA pilot study on the use of botulinum toxin in spasmodic torticollis_Can J Neurol Sci_ 12 314–316Occurrence Handle4084867Occurrence Handle1:STN:280:DyaL287gsFCksQ%3D%3D PubMedCAS Google Scholar
JK Tsui A Eisen AJ Stoessl S Calne DB Calne (1986)ArticleTitleDouble-blind study of botulinum toxin in spasmodic torticollis_Lancet_ 2 245–247Occurrence Handle2874278Occurrence Handle10.1016/S0140-6736(86)92070-2Occurrence Handle1:STN:280:DyaL283otlOntQ%3D%3D ArticlePubMedCAS Google Scholar